Boswellia (Boswellia serrata): Evidence, Dosage & Uses

Burseraceae · Ayurveda & TCM

Biological Overview

Boswellia serrata is a large tree native to India, also established in North Africa and the Middle East. It is distinct from Boswellia carterii, though both are commonly grouped under the terms olibanum (French) and frankincense (English). Boswellia serrata has a more turpentine-like scent but releases an excellent fragrance when burned.

HabitLarge Tree

Native RangeIndia · N. Africa · Middle East

Essential Oil Content5–10% (resin)

Traditional StatusOfficial Pharmacopoeia (India & China)

Botanical Classification

Taxonomy & Identification

Latin Name: Boswellia serrata Roxb.
Related Species: Boswellia carterii (distinct scent profile)
Family: Burseraceae
Common Names: Indian Frankincense, Boswellia, Salai, Olibanum
Parts Used: Oleo-gum-resin, collected after incising the trunk
Origin: India, naturalized to N. Africa and the Middle East

Ethnobotany & Traditional Use

History & Tradition

Boswellia resin has been used in India, China, and North Africa for millennia. Resin from various Boswellia species was traditionally burned during religious ceremonies — the smoke is said to induce a state conducive to meditation, prayer, and spiritual experience.

The resin is part of the official pharmacopoeia of both India and China. Traditional Ayurvedic medicine attributes it anti-inflammatory properties useful for rheumatic pain, digestive and respiratory tract inflammation, and various skin conditions. Traditional Chinese medicine uses it for rheumatic and menstrual pain, bruising, and other skin injuries.

It is cited by Avicenna in the "Canon of Medicine." ¹ Other Boswellia species show related promise: hydroalcoholic bark extract of Boswellia dalzielii improves ischemic brain injury in a rodent model through antioxidant and anti-inflammatory action, reducing serum levels of TNF, IL-1, and IL-6. ²

⚠ Not the Same as Other "Frankincense" Species

Boswellia serrata is regularly confused with Boswellia carterii under the shared terms "olibanum" and "frankincense" — but the two have distinct scent profiles and essential oil compositions that vary further by growing region.

Timeline

Ancient Ceremonial & Medicinal Use

Antiquity

Resin burned for millennia in religious ceremonies across India, China, and North Africa, valued for its meditative smoke.

Classical Medical Texts

Antiquity–Medieval

Cited by Avicenna in the "Canon of Medicine" among analgesic and anti-inflammatory substances.

Official Pharmacopoeia Status

Traditional

Part of the official pharmacopoeia of India and China; used in Ayurvedic and Traditional Chinese Medicine for rheumatic, digestive, respiratory, and skin conditions.

Modern Boswellic Acid Research

20th Century–Present

Characterization of boswellic acids as non-redox 5-lipoxygenase inhibitors, followed by clinical trials in arthritis, inflammatory bowel disease, and asthma. ¹⁰¹³

The Key Compounds

Boswellic Acids — Deep Dive

The triterpene acids behind Boswellia's specific, non-redox anti-inflammatory mechanism.

🧬

Triterpene Acid Structure

Boswellic acids are the principal triterpene acids of the oleo-gum-resin, alongside sterols and glycosaminoglycans such as 4-O-methyl-glucuronoarabinogalactan.

🎯

Non-Redox 5-Lipoxygenase Inhibition

Boswellic acids are specific, non-redox inhibitors of 5-lipoxygenase, blocking synthesis of inflammatory leukotrienes. ¹³

🛡️

Elastase & Glycosaminoglycan Protection

Inhibits leukocyte elastase and protects glycosaminoglycans from degradation, contributing to cartilage- and tissue-protective activity. ¹²

🌿

Synergy with Myrrh

Combined olibanum-myrrh preparations show potent anti-inflammatory synergy across multiple targets — IL-6, TNF, IL-1β, MAPK1, AKT1, and others — relevant to rheumatoid arthritis. ¹⁵¹⁶

⚠ Species & Sourcing Affect Content

Boswellic acid content varies with species and geography.

Essential oil composition of Boswellia resin varies dramatically by species and growing region — a good reason to choose products that specify Boswellia serrata and standardize to a stated boswellic acid content rather than "frankincense" generically.

Pharmaceutical Preparations

Parts Used & Available Forms

The oleo-gum-resin, collected after incising the trunk, is the only part used medicinally. No distinct preparation forms are separately documented in the available phytotherapy literature — clinical studies use the resin itself or extracts standardized to boswellic acid content.

Standardized Resin Extract

Oleo-gum-resin or its extract, standardized to boswellic acid content, taken orally or applied topically.

Resin / Standardized Extract

Clinical Dosimetry

Dosages

Dosing studied in clinical trials varies substantially by indication; duration and monitoring should be set by a qualified practitioner.

Form	Dose	Frequency	Context	Notes
Resin	300 mg	3× daily, 6 weeks	Asthma or Crohn's disease	Studied duration and dose from clinical trials. ³
Resin	1.5 g	3× daily	Same indications	Alternative dosing cited for asthma or Crohn's disease.
Extract	100–250 mg	2× daily	Knee osteoarthritis	Range across positive clinical trials for knee osteoarthritis. ⁴⁵

Phytochemistry

Composition

Oleo-gum-resin and essential-oil composition — no gemmotherapy (bud) fraction is documented for this species.

Oleo-Gum-Resin — Primary Constituents

Triterpene Acids (Boswellic Acids)Principal marker compounds

Present

SterolsStructural plant constituents

Present

Glycosaminoglycans4-O-methyl-glucuronoarabinogalactan

Present

Phenolic DerivativesIncluding tannins

Present

Essential OilHigh concentration within the resin ⁶

5–10%

Essential Oil — Primary Constituents

Proportions vary considerably by source and region. ⁷⁸

alpha-ThujeneDominant, highly variable monoterpene

22–70%

alpha-PineneMonoterpene

0–35%

LimoneneMonoterpene

1–10%

alpha-TerpineolMonoterpene alcohol

1–8%

Geraniol & beta-CaryophylleneMinor monoterpene alcohol and sesquiterpene

0–2.4%

Plant Properties — Pharmacodynamics

Six pharmacodynamic properties are documented for Boswellia, anchored in its boswellic-acid-driven anti-inflammatory pathway.

6 Properties Anti-inflammatory 5-LOX Inhibiting Clinical + Preclinical

🔥

Anti-inflammatory (Non-Steroidal)

Boswellic acids show anti-inflammatory activity in models of chronic arthritis and carrageenan-induced edema. ⁹¹⁰

🎯

5-Lipoxygenase Inhibiting

Inhibits 5-lipoxygenase and leukotriene release, relevant to ulcerative colitis, irritable bowel, bronchitis, and sinusitis; inhalation and consumption of olibanum also reduce asthma risk. ¹¹¹³¹⁴

🛡️

Elastase & Glycosaminoglycan Protective

Inhibits leukocyte elastase, leukotriene release, and glycosaminoglycan degradation. ¹²

💊

Analgesic

Combined extracts of myrrh and Boswellia carterii show evaluated anti-inflammatory and analgesic properties. ¹⁷

🧫

Immunomodulant

Modulates the immune system, with immunostimulant activity and stimulation of lymphocyte proliferation. ¹⁸¹⁹

🦠

Antiviral

Shows antiviral activity against Chikungunya virus. ³¹

Clinical Applications

Clinical Indications

Boswellia's traditional and clinical use centers on chronic inflammatory conditions of the joints, gut, and airways.

🦴

Chronic Joint & Airway Inflammation

Primary Indication

Chronic Inflammatory Joint Disease: studied for chronic inflammatory joint disease and peritumoral cerebral edema. ²⁰²³²⁴
Rheumatoid Arthritis: special extract (H15) studied in rheumatoid arthritis. ²⁸

🫄

Inflammatory Bowel Disease

Clinical Indication

Crohn's Disease & Ulcerative Colitis: 300 mg three times daily for 6 weeks reduced symptoms notably in 70% of Crohn's patients vs. 27% on placebo; 350 mg three times daily produced 82% remission (vs. 75% for sulfasalazine 1 g three times daily). ²¹²²²⁵
Comparable to Mesalazine: 1,200 mg three times daily appears as effective as mesalazine (1.5 g three times daily), with fewer adverse effects. ²⁶
Colonic Fibrosis Prevention: shown in animal models. ²⁷

🫁

Asthma & Airway Inflammation

Clinical Indication

Asthma, Bronchitis & COPD: studied via leukotriene synthesis inhibition, directly relevant to bronchoconstriction. ³

🦵

Joint & Topical Use

Clinical & Traditional Indication

Knee Osteoarthritis: positive randomized controlled trial supports use. ²⁹³⁰
Topical Use: applied externally for acne, fungal infections, and boils.

Pharmacodynamics

Mode of Action

Boswellia's anti-inflammatory effect converges on leukotriene pathway inhibition, with a distinctive combustion byproduct worth noting separately.

🧪

Leukotriene Synthesis Inhibition

Probable inhibition of leukotriene synthesis underlies much of Boswellia's anti-inflammatory activity.

🎯

Boswellic Acid Anti-Inflammatory Effect

Boswellic acids exert a direct anti-inflammatory effect, distinguished from steroidal anti-inflammatories by their specific, non-redox mechanism. ¹³

🔥

Combustion By-Product Note

Burning frankincense resin reportedly releases trans-hydrocannabinol, a close relative of THC, the compound credited with cannabis's psychotropic effects — a separate phenomenon from Boswellia's studied oral anti-inflammatory use.

🌿

Synergistic Multi-Target Action with Myrrh

Network pharmacology shows joint action on IL-6, TNF, IL-1β, MAPK1, AKT1, MAPK8, PIK3CA/R1, and EGFR pathways when Boswellia is combined with myrrh. ¹⁵¹⁶

Risk Profile

Safety & Interactions

Boswellia has a comparatively favorable safety record across trials, with minor GI effects as the main practical consideration.

⚠️

Adverse Effects

Overall Tolerability: efficacy described as encouraging without serious adverse effects across asthma, rheumatoid arthritis, Crohn's disease, and osteoarthritis trials. ³³
GI Effects: minor adverse effects, mainly gastrointestinal, are the most commonly reported issue. ³⁵³⁰
Animal Toxicity Data: no notable toxicity observed at 2 g/kg body weight in rats.

🚫

Contraindications & Interactions

Crohn's Relapse Prevention: efficacy uncertain for preventing Crohn's disease recurrence specifically, despite good tolerability. ³⁴
No Documented Interactions: the available source reports no notable pharmacokinetic or pharmacodynamic interactions.

✓ How to Use Boswellia More Safely

A Practical Safety Checklist

Take with food. This can minimize the mild GI effects that are the most commonly reported issue.
Match the dose to your condition. Studied doses vary widely, from 100 mg (osteoarthritis) to 1.5 g (asthma/IBD) — don't assume one dose fits every use.
Don't expect it to prevent Crohn's relapse specifically. A placebo-controlled trial found good safety but no efficacy advantage for that particular use.
Give it time. Most positive trials ran 6 weeks or longer before showing benefit.
Choose a standardized extract where possible, since boswellic acid content is the active marker and varies by species and source.
Talk to a provider first if you have a chronic inflammatory condition already under treatment, to coordinate care.

Clinical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare provider before starting Boswellia, particularly if you have a chronic inflammatory condition already under treatment.

Common Questions

Frequently Asked Questions

What is Boswellia (Indian frankincense) used for?

Boswellia is used for chronic inflammatory joint disease, inflammatory bowel disease including Crohn's disease and ulcerative colitis, asthma and airway inflammation, rheumatoid arthritis, and knee osteoarthritis, plus topical use for acne and fungal infections.

How does Boswellia work?

Its boswellic acids are specific, non-redox inhibitors of 5-lipoxygenase, blocking synthesis of inflammatory leukotrienes. They also inhibit leukocyte elastase and glycosaminoglycan degradation, contributing to its anti-inflammatory effect.

What is the typical Boswellia dosage?

Studied doses include 300 mg of resin three times daily for six weeks (asthma or Crohn's disease), or 1.5 g three times daily, and 100–250 mg of extract twice daily for knee osteoarthritis.

Is Boswellia safe? What are the side effects?

Boswellia's efficacy has been described as encouraging without serious adverse effects across asthma, rheumatoid arthritis, Crohn's disease, and osteoarthritis trials. Minor adverse effects, mainly gastrointestinal, are the most commonly reported issue.

Does Boswellia help osteoarthritis?

Yes. A randomized, double-blind, placebo-controlled trial found Boswellia serrata extract effective and well tolerated for knee osteoarthritis, and systematic reviews support benefit for knee osteoarthritis specifically.

Can Boswellia help inflammatory bowel disease?

Clinical trials in Crohn's disease and ulcerative colitis show meaningful symptom improvement, with one trial finding comparable results to sulfasalazine without its typical side effects. However, a separate placebo-controlled trial found good safety but no efficacy advantage specifically for preventing Crohn's disease relapse.

What's the difference between Boswellia serrata and other frankincense species?

Boswellia serrata is distinct from Boswellia carterii, though both are commonly called olibanum or frankincense. Boswellia serrata has a more turpentine-like scent, and essential oil composition varies meaningfully between species and even by growing region.

Is Boswellia the same as CBD or THC-related compounds?

No, but there is an interesting chemical connection: burning frankincense resin reportedly releases trans-hydrocannabinol, a close relative of THC, the compound credited with cannabis's psychotropic effects. This is a combustion byproduct, not the basis for Boswellia's studied anti-inflammatory use.

Sources

Bibliography

↑1. Mahdizadeh S, Khaleghi Ghadiri M, Gorji A. Avicenna's Canon of Medicine: a review of analgesics and anti-inflammatory substances. Avicenna J Phytomed. 2015;5(3):182–202.

↑2. Hamadjida A, Foudjih SN, Miaffo D, et al. Boswellia dalzielii bark extract mitigates ischemic brain injury via antioxidant and anti-inflammatory effects. Academia Biology. 2025;3.
DOI: 10.20935/AcadBiol7873 →

↑3. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998;3(11):511–514.
PubMed: PMID 9810030 →

↑4. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(3):416–429.
PubMed: PMID 29622343 →

↑5. Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85.
PubMed: PMID 18667054 →

↑6. Ojha PK, Poudel DK, Rokaya A, et al. Comparison of volatile constituents present in commercial and lab-distilled frankincense (Boswellia carteri) essential oils for authentication. Plants (Basel). 2022;11(16):2134.
PubMed: PMID 36015437 →

↑7. Gupta M, Rout PK, Misra LN, et al. Chemical composition and bioactivity of Boswellia serrata Roxb. essential oil in relation to geographical variation. Plant Biosyst. 2017.
DOI: 10.1080/11263504.2016.1187681 →

↑8. Singh B, Kumar R, Bhandari S, Pathania S, Lal B. Volatile constituents of natural Boswellia serrata oleo-gum-resin and commercial samples. Flavour Fragr J. 2007;22(2):145–147.
DOI: 10.1002/ffj.1772 →

↑9. Singh GB, Singh S, Bani S. Anti-inflammatory actions of boswellic acids. Phytomedicine. 1996;3(1):81–85.

↑10. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349–369.
PubMed: PMID 21553931 →

↑11. Al-Yasiry AR, Kiczorowska B. Frankincense — therapeutic properties. Postepy Hig Med Dosw (Online). 2016;70:380–391.
PubMed: PMID 27117114 →

↑12. Al-Yasiry AR, Kiczorowska B. Frankincense — therapeutic properties. Postepy Hig Med Dosw (Online). 2016;70:380–391. (Same source as ref. 11, cited separately by Wikiphyto for its elastase/glycosaminoglycan-related discussion.)
PubMed: PMID 27117114 →

↑13. Safayhi H, Mack T, Sabieraj J, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 1992;261(3):1143–1146.
PubMed: PMID 1602379 →

↑14. Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011;73(3):255–261.
Full Text (PMC) →

↑15. Li JS, Zhao ZZ, Miao XD, et al. [Mechanism of Olibanum-Myrrha in treatment of rheumatoid arthritis based on network pharmacology and molecular docking]. Zhongguo Zhong Yao Za Zhi. 2021;46(10):2371–2379.
PubMed: PMID 34047081 →

↑16. Zhao ZZ, Li JS, Su SL, et al. [Anti-inflammatory mechanism of active components in Olibanum and Myrrha based on network pharmacology and cell experiments]. Zhongguo Zhong Yao Za Zhi. 2021;46(21):5674–5682.
PubMed: PMID 34951221 →

↑17. Su S, Hua Y, Wang Y, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha and Boswellia carterii. J Ethnopharmacol. 2012;139(2):649–656.
PubMed: PMID 22178177 →

↑18. Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010;17(11):862–867.
PubMed: PMID 20696559 →

↑19. Mikhaeil BR, Maatooq GT, Badria FA, Amer MM. Chemistry and immunomodulatory activity of frankincense oil. Z Naturforsch C. 2003;58(3-4):230–238.
PubMed: PMID 12710734 →

↑20. Gupta PK, Samarakoon SM, Chandola HM, Ravishankar B. Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis). Ayu. 2011;32(4):478–482.
PubMed: PMID 22661840 →

↑21. Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23(3):341–349.
PubMed: PMID 16422993 →

↑22. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract. Z Gastroenterol. 2001;39:11–17.
PubMed: PMID 11215357 →

↑23. Ammon HP. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien Med Wochenschr. 2002;152(15-16):373–378.
PubMed: PMID 12244881 →

↑24. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100–1116.
PubMed: PMID 17024588 →

↑25. Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2(1):37–43.
PubMed: PMID 9049593 →

↑26. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15. Z Gastroenterol. 2001;39(1):11–17.
PubMed: PMID 11215357 →

↑27. Latella G, Sferra R, Vetuschi A, et al. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid. Eur J Clin Invest. 2008;38(6):410–420.
PubMed: PMID 18489401 →

↑28. Etzel R. Special extract of Boswellia serrata (H15) in the treatment of rheumatoid arthritis. Phytomedicine. 1996;3(1):91–94.
PubMed: PMID 23194870 →

↑29. Bannuru RR, Osani MC, Al-Eid F, Wang C. Efficacy of curcumin and Boswellia for knee osteoarthritis: systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(3):416–429.
PubMed: PMID 29622343 →

↑30. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee — a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3–7.
PubMed: PMID 12622457 →

↑31. von Rhein C, Weidner T, Henß L, et al. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. Antiviral Res. 2016;125:51–57.
PubMed: PMID 26611396 →

32. Ni X, Suhail MM, Yang Q, et al. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complement Altern Med. 2012;12:253.
PubMed: PMID 23237355 →

↑33. Ernst E. Frankincense: systematic review. BMJ. 2008;337:a2813.
PubMed: PMID 19091760 →

↑34. Holtmeier W, Zeuzem S, Preiss J, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy. Inflamm Bowel Dis. 2011;17(2):573–582.
PubMed: PMID 20848527 →

↑35. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013;13(1):7–12.
PubMed: PMID 23472485 →

Additional Sources

Kimmatkar N, et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee. Phytomedicine. 2003;10(1):3–7.

Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol. 1993;38(2-3):113–119.
PubMed: PMID 8510458 →

Poeckel D, Tausch L, Kather N, Jauch J, Werz O. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase. Mol Pharmacol. 2006;70(3):1071–1078.
PubMed: PMID 16788089 →